guhjy's Pfeffer:MA [15 articles] Export

Recent papers posted to guhjy's library by the author Pfeffer:MA. You can also see everyone's Pfeffer:MA.

	A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. [My Copy] The New England journal of medicine (30 October 2009) by Marc A. Pfeffer, Emmanuel A. Burdmann, Chao-Yin Y. Chen, et al.Mark E. Cooper, Dick de Zeeuw, Kai-Uwe U. Eckardt, Jan M. Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J. McMurray, Patrick Parfrey, Hans-Henrik H. Parving, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert Toto, the TREAT Investigators posted to rct outcome epo dm ckd by guhjy on 2009-11-09 14:02:21 as along with 1 person benjaminbertrand
	Albuminuria in chronic heart failure: prevalence and prognostic importance. [My Copy] Lancet, Vol. 374, No. 9689. (15 August 2009), pp. 543-550. by Colette E. Jackson, Scott D. Solomon, Hertzel C. Gerstein, et al.Sofia Zetterstrand, Bertil Olofsson, Eric L. Michelson, Christopher B. Granger, Karl Swedberg, Marc A. Pfeffer, Salim Yusuf, John J. McMurray, CHARM Investigators and Committees posted to uae rct chf arb by guhjy on 2009-09-23 00:46:19 as
	Dual Renin-Angiotensin System Blockade and Kidney Disease [My Copy] J Am Coll Cardiol, Vol. 54, No. 3. (14 July 2009), pp. 278-a-279. by Hans-Henrik Parving, Barry M. Brenner, John J. V. Mcmurray, et al.Dick de Zeeuw, Steven M. Haffner, Scott D. Solomon, Nish Chaturvedi, Marc A. Pfeffer posted to ckd aceiarb by guhjy on 2009-09-03 04:48:41 as
	A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. [My Copy] The New England journal of medicine, Vol. 332, No. 11. (16 March 1995), pp. 706-711. by K. Lindpaintner, M. A. Pfeffer, R. Kreutz, et al.M. J. Stampfer, F. Grodstein, F. LaMotte, J. Buring, C. H. Hennekens posted to ace method snp by guhjy on 2009-06-23 10:20:28 as
	Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. [My Copy] Kidney international. Supplement, No. 92. (November 2004) by N. S. Anavekar, D. J. Gans, T. Berl, et al.R. D. Rohde, W. Cooper, A. Bhaumik, L. G. Hunsicker, J. L. Rouleau, J. B. Lewis, C. Rosendorff, J. G. Porush, P. L. Drury, E. Esmatjes, I. Raz, P. Vanhille, F. Locatelli, S. Goldhaber, E. J. Lewis, M. A. Pfeffer posted to bp cv dn idnt uae by guhjy on 2009-01-12 04:17:11 as
	Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. [My Copy] Circulation, Vol. 114, No. 1. (4 July 2006), pp. 26-31. by S. D. Solomon, M. M. Rice, K. A Jablonski, et al.P. Jose, M. Domanski, M. Sabatine, B. J. Gersh, J. Rouleau, M. A. Pfeffer, E. Braunwald, posted to acei ckd peace rct by guhjy on 2008-09-25 09:14:08 as
	Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. [My Copy] European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology, Vol. 10, No. 2. (February 2008), pp. 157-163. by R. A. Weir, J. J. McMurray, M. Puu, et al.S. D. Solomon, B. Olofsson, C. B. Granger, S. Yusuf, E. L. Michelson, K. Swedberg, M. A. Pfeffer, posted to acei arb chf rct aceiarb by guhjy on 2008-07-21 04:10:12 as
	Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. [My Copy] Circulation, Vol. 115, No. 24. (19 June 2007), pp. 3111-3120. by E. O'Meara, T. Clayton, M. B. McEntegart, et al.J. J. McMurray, I. L. Piña, C. B. Granger, J. Ostergren, E. L. Michelson, S. D. Solomon, S. Pocock, S. Yusuf, K. Swedberg, M. A. Pfeffer, posted to arb chf gender rct by guhjy on 2008-07-21 04:09:11 as
	Anemia treatment in chronic kidney disease: shifting uncertainty. [My Copy] Heart failure reviews, Vol. 13, No. 4. (December 2008), pp. 425-430. by Marc A. Pfeffer posted to anemia ckd epo uncertainty by guhjy on 2008-06-17 05:29:17 as
	Critical missing data on erythropoiesis-stimulating agents in CKD: first beat placebo. [My Copy] Am J Kidney Dis, Vol. 51, No. 3. (March 2008), pp. 366-369. by M. A. Pfeffer posted to ckd epo rct by guhjy on 2008-03-03 02:33:58 as
	Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. [My Copy] Circulation, Vol. 116, No. 23. (4 December 2007), pp. 2687-2693. by S. D. Solomon, J. Lin, C. G. Solomon, et al.K. A. Jablonski, M. M. Rice, M. Steffes, M. Domanski, J. Hsia, B. J. Gersh, J. M. Arnold, J. Rouleau, E. Braunwald, M. A. Pfeffer, posted to cad cv uae by guhjy on 2007-12-14 15:19:55 as
	Angiotensin-converting-enzyme inhibition in stable coronary artery disease. [My Copy] N Engl J Med, Vol. 351, No. 20. (11 November 2004), pp. 2058-2068. by E. Braunwald, M. J. Domanski, S. E. Fowler, et al.N. L. Geller, B. J. Gersh, J. Hsia, M. A. Pfeffer, M. M. Rice, Y. D. Rosenberg, J. L. Rouleau, posted to acei cad cv rct by guhjy on 2007-12-14 14:44:41 as
	Kidney disease and cardiovascular risk. [My Copy] Annu Rev Med, Vol. 58 (2007), pp. 123-139. by M. Tonelli, M. A. Pfeffer posted to no-tag by guhjy on 2007-11-11 02:23:23 as
	An ongoing study of anemia correction in chronic kidney disease. [My Copy] N Engl J Med, Vol. 356, No. 9. (1 March 2007), pp. 959-961. by M. A. Pfeffer, posted to no-tag by guhjy on 2007-09-29 03:10:48 as
	Heart failure. [My Copy] Lancet, Vol. 365, No. 9474. (3 2005), pp. 1877-1889. by J. J. McMurray, M. A. Pfeffer posted to no-tag by guhjy on 2007-07-30 16:52:48 as along with 2 people sfedson cherrie

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Pfeffer:MA

ckd	1734
rct	1194
dn	1072
dm	996
cancer	979
ma	969
cv	904
hd	856
tgfb	791
snp	760
bp	633
ros	569
meta-analysis	515
uae	496
stats	476
kidney	469
software	458
mouse	452
genetics	444
mirna	442
pt	417
proteomics	409
mortality	408
inflammation	363
fbl	359
rat	355
proteinuria	354
pcr	348
tw	345
acei	328
db	326
gdl	325
test	325
inhibitor	315
urine	315
arb	310
ms	306
method	306
apoptosis	302
hcv	300
age	297
mc	294
r	291
aging	287
biomarker	285
irs	279
ppi	275
bias	274
bayes	273
akt	273
gwa	267
aki	264
mtor	263
aii	260
hg	257
nutrition	255
rnai	242
emt	242
ub	233
egfr	230
fibrosis	230
p53	230
cox	226
smad	220
pbmc	220
obesity	219
metab	212
pi3k	212
drug	210
hcc	210
gn	208
hypoxia	204
1	200
herb	197
albumin	189
lc	185
erk	185
collagen	180
longitudinal	179
hif	179
lmm	178
nfkb	175
gfr	174
stz	174
ua	170
pubmed	169
epigenetics	168
japan	165
gender	162
p38	162
cea	160
lead	159
power	159
rage	159
cadmium	158
dna-damage	156
bioinf	155
ref	154
genomics	148
stata	147
vitamin-d	146
ctgf	144
network	142
liver	138
screening	137
rt	135
diet	132
seq	131
protein	129
company	129
phosphorylation	127
go	125
systems-biology	124
pathway	122
cell-cycle	121
mt	120
no	120
esrd	117
pkc	117
book	117
lipid	117
creatinine	115
kinase	113
statin	113
senescence	106
podocyte	105
proliferation	104
mapk	103
regression	103
fish	103
pd	102
case-control	102
gfr-formula	102
imputation	101
s6k	101
cad	100
imaging	99
rx	98
plasmid	97
multiplicity	96
cloning	96
methylation	95
observational	95
p21	95
pediatric	95
insulin	94
recurrent	94
sirt	93
blood	91
nox	90
tnf	90
betel	90
nhanes	90
pparg	89
website	89
phenotype	88
toxicology	88
chf	88
diagnosis	87
cytokine	87
anemia	86
immunity	86
uti	85
src	85
stat	84
at1	84
lr	84
china	83
epo	82
nonp	81
oat	81
p	81
cachexia	80
hapmap	80
environment	79
ebm	79
ca	79
hypertrophy	78
primer	78
gout	78
review	75
qms	74
promoter	73
missing	73
gene-therapy	73
autophagy	73
eqtl	72
ko	72
surrogate	72
gene-list	72
lpd	72
ace	71
mv	71
salt	70
egf	69
stone	69
phd	69
signaling	68
cox2	68
uncertainty	66
mgo	66
tin	65
mirna-target	65
normalization	65
association	64
causation	63
yeast	63
foxo	63
chinese	63
glycemia	63
acid-base	63
me	62
enddysf	62
simulation	62
2dge	62
hts	61
jnk	61
gpcr	61
pla2	61
smoking	61
confounding	61
uuo	60
sas	60
outcome	60
ptm	60
pe	60
change	60
melamine	60
avf	60
oral	59
cost	59
eif	59
infection	59
ifn	59
shc	59
alcohol	58
crp	58
mmp	58
pls	57
llcpk1	57
nrk49f	57
urate-transporter	57
pai1	57
achr	57
robust	57
model-selection	56
pdgf	56
hsp	56
fluorescence	56
hk2	56
semantic	56
calibration	56
aceiarb	56
goldstd	55
ratio	55
oglcnac	55
competing-risk	55
estrogen	54
function	54
workflow	54
iron	54
bone	54
p-value	54
ckd-progression	53
std	53
k	53
dipstick	53
qc	52
ncrna	52
renoprotection	52
rho	52
ace2	52
histone	52
stem-cell	52
epidemiology	51
atm	51
normoalbuminuria	51
pth	51
dimerization	51
lod	51
fgf	51
reasoning	50
arsenic	50
matlab	50
cyclin-d1	50
mercury	50
vegf	50
risk-ratio	50
hsc	49
adpkd	49
epistasis	49
ab	49
antibiotics	49
tf	49
graph	49
gene-environment	49
klotho	48
breakpoint	48
pld	48
core-curriculum	48
nrk52e	48
ukm	48
joint-model	47
protein-microarray	47
mesangial	47
ffpe	47
endothelium	47
spot-urine	47
pooling	47
ngal	47
aspirin	46
cystatin	46
il6	46
fdr	46
4ebp	46
hdac	46
hgf	46
ecm	46
p27	46
aldosterone	45
writing	45
semip	45
metal	45
biosensor	45
ras	45
prevention	45
rapamycin	45
fgf23	45
variability	44
ancova	44
wnt	44
interaction	43
enos	43
klf	43
translation	43
dub	43
sle	43
design	43
cnv	43
bia	43
na	43
sumo	42
ccb	42
icu	42
good	42
bmi	42
agreement	42
roc	42
igf	41
diuretics	41
er-stress	41
stroke	41
tgfbr	41
alignment	40
fuzzy	40
gene-targeting	40
ampk	40
wga	40
dbdb	40
risk	40
qtl	39
hepatocyte	39
hyperfiltration	39
dry-bw	39
ap1	38
protein-complex	38
myc	38
igan	38
urinalysis	38
sage	38
asia	38
fabp	37
adh	37
tea	37
bh4	37
propensity	37
animal	37
mtorc1	37
haplotype	37
tlr	37
hematuria	37
antisense	37
cardiorenal	36
adenosine	36
emr	36
angiogenesis	36
rsk	36
web20	36
omics	36
catenin	36
megalin	36
inflammasome	36
cre	35
chemogenomics	35
annotation	35
gsk	35
subgroup	35
s100b	35
adduct	35
candidate-gene	35
proteasome	34
reverse-epidemiology	34
pathology	34
sepsis	34
cross-species	34
calcification	34
threshold	34
msm	34
attrition	34
snx	33
coffee	33
zeb	33
ns	33
nephrotoxicity	33
rca	33
exercise	33
cage	33
fibronectin	33
sp1	33
integrin	33
sarcopenia	33
text-mining	32
addgene	32
zfn	32
effect-size	32
browser	32
il1	32
end-point	32
affy	32
gllamm	31
orbitrap	31
emsa	31
risk-difference	31
ecology	31
blast	31
vsmc	31
fc	31
hospitalization	31
transactivation	31
steroid	31
family	31
frailty	31
set	31
heritability	31
macrophage	31
mw	30
abp	30
bmp	30
membrane-protein	30
notch	30
knockout	30
rtk	30
staging	30
creb	30
transporter	30
pka	29
3	29
s100	29
ai	29
rvh	29
nicotinic	29
reporter	29
et	29
nutrient	29
validation	29
extraction	29
grn	29
ub-ligase	28
race	28
scaling	28
time-dependent	28
acetylation	28
mutagenesis	28
gee	28
geo	28
perindopril	28
spla2	27
carcinogen	27
ndrd	27
mendelian	27
pdz	27
human	27
ce	27
ck2	27
classification	27
cari	27
hyaluronan	26
gsh	26
thp	26
silac	26
muscarinic	26
metagenomics	26
hplc	26
hba1c	26
renin	26
agt	26
mtorc2	26
soy	25
ptp	25

guhjy's Pfeffer:MA [15 articles] Export

guhjy's tags